Bootstrapping methodology in Bioequivalence [Regulatives / Guidelines]

posted by Achievwin – US, 2021-08-17 22:30 (68 d 11:13 ago) – Posting: # 22526
Views: 539

Anyone have knowledge on whether any regulatory agency accepts bootstrapping methodology (other than for sparse sampling) for establishing bioequivalence in PK/CE studies?

Thanks a lot for your feed back

Complete thread:

Activity
 Admin contact
21,756 posts in 4,548 threads, 1,544 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Monday 09:43 CEST (Europe/Vienna)

The plural of anecdote is data.    Raymond Wolfinger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5